NCT03394742 is a NA clinical trial of Peer support in Breast Cancer, sponsored by University of Jyvaskyla.

Who is sponsoring NCT03394742?

NCT03394742 is sponsored by University of Jyvaskyla.

What drugs are being tested in NCT03394742?

Interventions in NCT03394742: Peer support.

What condition does NCT03394742 study?

NCT03394742 studies Breast Cancer.

Is NCT03394742 still recruiting?

NCT03394742 is currently completed. Last updated 9 January 2018.

Last reviewed 2018-01-09 · How we verify

NCT03394742

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Peer Support on Quality of Life in Recently Diagnosed Breast Cancer Patients

Completed NA Last updated 9 January 2018

What this trial tests

NA trial testing Peer support in Breast Cancer in 260 participants. Completed in 30 October 2016.

Timeline

1 May 2014

Primary endpoint
30 June 2015

30 October 2016

Quick facts

Lead sponsor	University of Jyvaskyla
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	260
Start date	1 May 2014
Primary completion	30 June 2015
Estimated completion	30 October 2016
Sites	1 location across Finland

Drugs / interventions tested

Peer support

Conditions studied

Breast Cancer — all drugs for Breast Cancer →

Sponsor

University of Jyvaskyla

Who can join

Eligibility, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study examines effectiveness of peer support of breast cancer patients. Half of the participants received peer support via telephone in addition to usual care and another half are give the usual care only.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Peer support

Trials testing the same drug.

NCT07025109 — Assessing Peer Support for Physical Activity in Women With HIV and Hypertension · NA · recruiting
NCT06677905 — SCI&U Peer Health Coaching Program for Individuals Newly Discharged From Inpatient Rehabilitation · NA · recruiting
NCT05519553 — Peer Support Impact on Therapeutic Adherence in Patients With Multiple Sclerosis · NA · unknown
NCT05133726 — Peer and Text Message Support to Reduce Readmission Rates for Patients Discharged From Acute Psychiatric Care · NA · active not recruiting
NCT04856241 — Making Football Safer for Women: Implementing an Injury Prevention Program · NA · unknown

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other University of Jyvaskyla trials

Trials by the same sponsor.

NCT07500922 — Menopause Effects on Cortico-reticular Functioning · NA · not yet recruiting
NCT07406412 — Hormonal Regulation of Cardiometabolic Health Study · not yet recruiting
NCT06573086 — Resistance Training, Detraining, and Retraining Study 2024 (TraDeRe2024) · NA · recruiting
NCT05874986 — Why do People Respond Differently to Resistance Training? · NA · completed
NCT05553769 — Resistance Training, Detraining, and Retraining Study 2022 · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03394742 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Jyvaskyla
Last refreshed: 9 January 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03394742.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing